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ABSTRACT
Objective: To develop and psychometrically evaluate
an audio digitised tool for assessment of
comprehension of informed consent among low-
literacy Gambian research participants.
Setting: We conducted this study in the Gambia
where a high illiteracy rate and absence of standardised
writing formats of local languages pose major
challenges for research participants to comprehend
consent information. We developed a 34-item
questionnaire to assess participants’ comprehension of
key elements of informed consent. The questionnaire
was face validated and content validated by
experienced researchers. To bypass the challenge of a
lack of standardised writing formats, we audiorecorded
the questionnaire in three major Gambian languages:
Mandinka, Wolof and Fula. The questionnaire was
further developed into an audio computer-assisted
interview format.
Participants: The digitised questionnaire was
administered to 250 participants enrolled in two clinical
trials in the urban and rural areas of the Gambia. One
week after first administration, the questionnaire was
readministered to half of the participants who were
randomly selected. Participants were eligible if enrolled
in the parent trials and could speak any of the three
major Gambian languages.
Outcome measure: The primary outcome measure
was reliability and validity of the questionnaire.
Results: Item reduction by factor analysis showed that
21 of the question items have strong factor loadings.
These were retained along with five other items which
were fundamental components of informed consent.
The 26-item questionnaire has high internal
consistency with a Cronbach’s α of 0.73–0.79 and an
intraclass correlation coefficient of 0.94 (95% CI 0.923
to 0.954). Hypotheses testing also showed that the
questionnaire has a positive correlation with a similar
questionnaire and discriminates between participants
with and without education.
Conclusions: We have developed a reliable and valid
measure of comprehension of informed consent
information for the Gambian context, which might be
easily adapted to similar settings. This is a major step
towards engendering comprehension of informed
consent information among low-literacy participants.
INTRODUCTION
Conduct of clinical trials in developing coun-
tries faces considerable ethical challenges.1 2
One of these constraints includes ensuring
that informed consent is provided in a com-
prehensible manner that allows potential
participants to freely decide whether or not
they are willing to enrol in the study.
According to the Helsinki Declaration3 and
other internationally agreed guidelines,4 5
special attention should be given to the spe-
ciﬁc information needs of potential partici-
pants and to the methods used to deliver the
information. This implies, among other
things, that the information must be pro-
vided in the participant’s native language. If
Strengths and limitations of this study
▪ Our study demonstrates that a locally appropriate
informed consent tool can be developed and sci-
entifically tested to ensure an objective assess-
ment of comprehension of informed consent
information among low and non-literate research
participants.
▪ This is capable of minimizing participants’ vul-
nerability and ultimately engenders genuine
informed consent.
▪ Our findings are based on data collected from
specific research context in a small country with
three major local languages. Further research is
needed to validate this tool in other settings.
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the informed consent documents have been originally
written in one of the major international languages,
they must be translated to the local languages of poten-
tial study participants.6 7 The translated documents are
subsequently back-translated by another independent
group to the initial language to conﬁrm that the original
meaning of the contents of the document is retained.
In sub-Saharan Africa, this process may become
extremely challenging because many research concepts
such as randomisation and placebo do not have direct
interpretations in the local languages.8 Furthermore, in
some African countries, local languages exist only in
oral forms and they do not have standardised writing
formats, which makes written translation and back-
translations of informed consent documents not only
impractical, but also less precise.9 Further adding to
these difﬁculties are the high rates of illiteracy and func-
tional illiteracy in such contexts, which may contribute
to the socioeconomical vulnerability of these research
populations.10
Nevertheless, it remains crucial to ensure an under-
standing of vulnerable participants about study informa-
tion because the voluntary nature of informed consent
could be easily jeopardised by cultural diversity, an incor-
rect understanding of the concept of diseases, a mix of
communal and individual decision-making, huge social
implications of some infectious diseases and inadequate
access to care.11 Use of an experiential model at the
pre-enrolment, enrolment and postenrolment stages of
clinical research11 as well as tailoring of cultural and lin-
guistic requirements to the informed consent process
has been reported to improve comprehension of basic
research concepts.12
Furthermore, international guidelines3–5 emphasise
that informed consent must be based on a full under-
standing of the information conveyed during the consent
interview. In contexts characterised by high linguistic vari-
ability and illiteracy rates, the use of tools to ascertain
comprehension of study information conveyed during
the informed consent process may be recommended.
These tools could vary from a study quiz to complex ques-
tionnaires.13 14 Tools that have been used extensively to
assess informed consent comprehension include Brief
Informed Consent Evaluation Protocol (BICEP),15
Deaconess Informed Consent Comprehension Test
(DICCT)16 and the Quality of Informed Consent test
(QuIC).17 These tools were limited in usability across
other studies because they were developed for speciﬁc
trials. In addition, because they were designed for the
developed world, they are not easily adaptable to African
research settings. To the best of our knowledge, there is
no published article to support the availability of an
appropriate measure of informed consent comprehen-
sion in African research settings. To comply with the
ethical principle of respect for persons,4 a systematically
developed tool could contribute to achieving an
adequate measurement of comprehension of study infor-
mation among the vulnerable research population in
Africa. This is consistent with a framework incorporating
aspects that reﬂect the realities of participants’ social and
cultural contexts.11
This study was designed to develop and psychometric-
ally evaluate an informed consent comprehension ques-
tionnaire for a low-literacy research population in the
Gambia, for whom English is not the native language.
This is the ﬁrst step towards contextualising strategies of
delivering study information to research participants;
objectively measuring their comprehension of the infor-
mation using a validated tool and, based on this, improv-
ing the way information is delivered during informed
consent process.
DISEASE PROFILE IN THE GAMBIA AND RESEARCH
ACTIVITIES OF THE MEDICAL RESEARCH COUNCIL
UNIT, THE GAMBIA
The Gambia is one of the smallest West African countries
with an estimated population of 1.79 million people.18
According to the 2012 World Bank report, Gambia’s total
adult literacy rate was 45.3% while the adult literacy rate of
the female population, which constitutes a large majority
of clinical trial participants, was 34.3%.19
Three major ethnolinguistically distinct groups,
Mandinka, Fula and Wolof, populate the country. The
languages do not have standardised writing formats and
they are not formally taught in schools. The ethnic
groups have similar sociocultural institutions such as the
extended family system and patrilineal inheritance.
Health-seeking behaviour is governed by traditions rather
than modern healthcare norm. Because the people live
in a closely knit, extended family system, important deci-
sions like research participation is taken within the
kinship structure.20
Like other low-income countries characterised by social
and medical disadvantages,21 infectious diseases such as
malaria, pneumonia and diarrhoea constitute major
reasons for hospital presentations in the Gambia.22 In
addition to the high disease burden, low literacy, a high
poverty rate and inadequate access to healthcare tend to
make the people vulnerable to research exploitation.21
The Medical Research Council (MRC) Unit in the
Gambia was established to conduct biomedical and trans-
lational research into tropical infectious diseases. The insti-
tute has key northern and southern linkages and a track
record of achievements spanning over 67 years. The
research portfolio of MRC covers basic scientiﬁc research,
large epidemiological studies and vaccine trials. Important
recent and current vaccine trials include those on malaria,
tuberculosis, HIV, Haemophilus inﬂuenzae type B, measles,
pneumococcal and the Gambia Hepatitis Intervention
study. Preventive research interventions include intermit-
tent preventive treatment with sulfadoxine-pyrimethamine
versus intermittent screening and treatment of malaria in
pregnancy, a cluster randomised controlled trial on indoor
residual spraying plus long-lasting insecticide impregnated
nets. Ethical conduct of these studies takes place through
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sustained community involvement and engagement of par-
ticipants as research partners.20
METHODS
Study design
Questionnaire development
The items on the questionnaire were generated from
the basic elements of informed consent obtained from
an extensive literature search on guidelines for context-
ual development of informed consent tools,23–32 inter-
national ethical guidelines3–5 and operational guidelines
from the Gambia Government/Medical Research
Council Joint Ethics Committee.33
We identiﬁed and generated a set of question items on
15 independent domains of informed consent. These
domains are voluntary participation, rights of withdrawal,
study knowledge, study procedures, study purpose, blind-
ing, conﬁdentiality, compensation, randomisation, auton-
omy, meaning of giving consent, beneﬁts, risks/adverse
effects, therapeutic misconception and placebo.
Because evidence has shown the deﬁciencies of using
one question format in assessing comprehension of
informed consent information,30 we developed a total of
34 question items under three different response
formats. These response options are a combination of
Yes/No/I don’t know, multiple choice and open ended
with free text response options. The inclusion of the ‘I
don’t know’ option was meant to avoid restricting parti-
cipants to only two options of ‘yes or no’, which is
capable of inducing socially desirable responses and also
helps to reduce guesswork.
The questionnaire was made up of ﬁve sections: the
ﬁrst section contains 10 closed ended and 7 follow-up
question items; the second section has 6 single choice
response items; the third section has 4 multiple choice
response items; the fourth section has 7 free-text open-
ended question items. The last section has 9 questions
on sociodemographic information of participants and
these were not included in the psychometric analysis of
the questionnaire.
The follow-up question items were included in the ﬁrst
section to ensure that the responses given by participants
truly reﬂected their understanding as asked in the
closed-ended questions, for example, “Have you been told
how long the study will last? ” was followed by “If yes, how many
months will you be in this study? ”. No response options were
given and the participants were expected to give the study
duration based on their understanding of information
given during the informed consent process. The order of
responses to the questions was reversed for some items to
avoid participants defaulting to the same answer for each
question.
The use of multiple choice and open-ended response
items was meant to explore participants’ ‘actual’ under-
standing of study information, because this could not be
adequately measured using the closed-ended response
options.
To enable non-literate participants understand how to
answer questions under multiple and open-ended
response options, we included locally appropriate sample
question items before the main questions. For example,
‘Domoda’ soup is made from: a. Bread, b. Groundnut, c. Yam,
d. Orange. Groundnut is the correct response and partici-
pants were directed to choose only one correct response
in the question items that followed the sample question.
For items with multiple response options, we included:
“Which of these are Gambian names for a male child: a. Fatou,
b. Lamin, c. Ebrima, d. Isatou.” The correct responses are
Lamin and Ebrima; participants were directed to choose
more than one correct response that applies to the ques-
tion items.
As the questionnaire was intended to be used across
different clinical trials, we developed question items that
aimed to be applicable to most clinical trials and yet spe-
ciﬁc to individual trials. This was achieved with the inclu-
sion of open-ended question items in which participants
could give trial-speciﬁc responses. An example of this
was: “What are the possible unwanted effects of taking part in
this study? ” which allowed participants to explain in his/
her words the adverse events peculiar to the clinical
trials in which he/she is participating.
Face and content validity
Face validity was performed to assess the appearance of
the questionnaire regarding its readability, clarity of words
used, consistency of style and likelihood of target partici-
pants being able to answer the questions. Content validity
was performed to establish whether the content of the
questionnaire was appropriate and relevant to the context
for which it was developed.34 After generating the question
items, we requested ﬁve researchers: two from the London
School of Hygiene and Tropical Medicine UK (LSHTM)
and three from MRC, the Gambia, who are experienced
in clinical trials methodology, bioethics and social science
methods to review the English version of the questionnaire
for face and content validity. All of them agreed that essen-
tial elements of informed consent information were
addressed in the questionnaire, and that the items
adequately covered the essential domains of informed
consent, with special attention to those whose understand-
ing may be especially challenged in African research set-
tings. They also supported the use of multiple response
options as being capable of eliciting appropriate responses
that might reﬂect a true ‘understanding’ of participants.
One of the reviewers recommended presenting the item
in the form of a question instead of a statement, for
example, “I have been told that I can freely decide to take part in
this study” was changed to “Have you been told you can freely
decide to take part in this study? ”. The response option was
also changed from True/False to Yes/No.
We further gave the revised English version of the
questionnaire to three experienced ﬁeld assistants at
MRC and three randomly chosen laypersons to assess
the clarity and appropriateness of the revised question
items and their response options. The laypersons were
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selected randomly from a list of impartial witnesses by
choosing one person each from three ethnolinguistic
groups in the Gambia. They independently agreed that
the questions were clear, except for three items addres-
sing conﬁdentiality, compensation and the right to with-
draw. On the basis of these feedbacks, we reworded the
question items to improve clarity. The question on conﬁ-
dentiality was reframed from “Will non-MRC workers
have access to your health information?” to “Will anyone
not working with MRC know about your research infor-
mation?”. Similarly, “Will you be rewarded for taking
part in this study?” was changed to “Will you receive
money for taking part in this study?”.
Audiorecording in three local languages and development
into a digitised format
Owing to the lack of acceptable systems of writing
Gambian local languages, the question items were audio-
recorded in three major Gambian languages, Mandinka,
Wolof and Fula, by experienced linguistic professionals
who are native speakers of the local languages and are
also familiar with clinical research concepts. Audio back-
translations were made for each language by three inde-
pendent native speakers and corrections were made in
areas where translated versions were not consistent with
the English version. A ﬁnal audio proof was conducted
by three clinical researchers (native speakers) who inde-
pendently conﬁrmed that the translated versions
retained the original meaning of the English version.
The revised questionnaire was developed into an audio
computer-assisted interview format at the School of
Medicine, Tufts University, Boston, USA. In conjunction
with the MRC community relations ofﬁcer, we identiﬁed
and selected locally acceptable symbols and signs, for
example, star, moon, house, ﬁsh, bicycle, to represent the
response options. The question items were serially devel-
oped into the digitised format and draft copies were sent
to the ﬁrst author, MOA, for review at each stage. After
ensuring that the wordings of the paper questionnaire
were consistent with the digitised version, translated
audios in Mandinka, Wolof and Fula were subsequently
recorded as voice-overs on the digitised questionnaire,
which will be subsequently referred to as the Digitised
Informed Consent Comprehension Questionnaire
(DICCQ) in this manuscript.
Piloting
On completion of the initial development, DICCQ was
piloted among 18 mothers of infants participating in an
ongoing malaria vectored vaccine trial at the MRC
Sukuta ﬁeld site (ClinicalTrials.gov NCT01373879). The
ﬁeld site is located about 5 km from the MRC ﬁeld site
targeted for ﬁeld testing of the questionnaire. DICCQ
was administered through an interviewer (MOA) on a
computer laptop in a private consultation room within
the Sukuta ﬁeld site. After entering the participant’s
assigned identiﬁcation number and interviewer’s initials
into DICCQ, the participant’s local language of choice
was selected on the computer screen. Operated by
MOA, the question items were serially read aloud to the
participants in the local language with the click of a
button on the lower toolbar of the computer screen and
a ‘forward arrow’ button to move to the next question
item. Participants answered either by vocalising their
responses or by pointing to the symbols on the com-
puter screen that corresponded to their choice of
responses. The participants generally reported the ques-
tionnaire to be clear and easy to follow. The audio trans-
lations were also accepted as conforming with the
dialects spoken by the majority of Gambians. The
average administration time was 29.4 min. Suggestions
were made to include ‘backward’, ‘repeat’ and ‘skip’
function buttons in the computer toolbar. These amend-
ments were incorporated into the ﬁnal version of the
digitised questionnaire.
Field testing
The ﬁnal version of DICCQ (see online supplementary
appendix 1) was tested sequentially among participants
in two clinical trials. The two sites were selected for ﬁeld
testing of the questionnaire based on some similarities
of the clinical trials taking place simultaneously at the
two diversely distinct research communities within the
Gambia.
The ﬁrst ﬁeld test took place from 4 to 20 February
2013 among mothers of children enrolled in an
ongoing randomised controlled, observer blind trial that
aimed to evaluate the impact of two different formula-
tions of a combined protein-polysaccharide vaccine on
the nasopharyngeal carriage of Streptococcus pneumoniae
in Gambian infants at the Fajikunda ﬁeld site of MRC
(ClinicalTrials.gov NCT01262872). The site is located
within an urban health centre, about 25 km south of the
capital, Banjul. A total of 1200 infants were enrolled in
the trial and mothers brought their children for a total
of six study visits over a period of one year.
The second ﬁeld test took place from 22 February to
15 March 2013 in villages around Walikunda, about
280 km east of Banjul, among participants in an
ongoing randomised controlled, observer blind trial
(http://www.who.int/whopes/en/). The study was
designed to compare the efﬁcacy of two different doses
of a newly developed insecticide with the conventional
one, used for indoor residual spraying for malaria vector
control in the Gambia. Over 900 households in 18 vil-
lages around the Walikunda ﬁeld station of MRC were
randomly selected to receive any of the three doses of
insecticides. Household participants gave informed
consent before indoor spraying of the insecticides.
Entomologists visited the households every month for
6 months to collect mosquitoes and interviewed the par-
ticipants for perception of efﬁcacy and adverse effects of
the insecticides.
In the two studies, written informed consent was
obtained based on the English version of the respective
study information sheets. These were explained in the
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local languages by trained ﬁeld staff, in the presence of
an impartial witness in case of illiteracy. Similarly, prior
to administering DICCQ at each trial site, written
informed consent was obtained from participants or
their parents. One week after ﬁrst administration,
DICCQ was readministered to the randomly selected
group among the participants.
After obtaining a written informed consent, trained
interviewers administered DICCQ on a laptop computer
to each participant in his/her preferred local language
in noise-free consulting rooms at the MRC facility
located within the Fajikunda Health Centre and at desig-
nated areas within the households in Walikunda villages.
In addition, at the end of the ﬁrst questionnaire admin-
istration, each participant in the two sites was adminis-
tered an Informed Consent Questionnaire (ICQ),35
which has been validated in a different context. Brieﬂy,
ICQ consists of two subscales: the ‘understanding’ sub-
scale, which has four question items, and the ‘satisfac-
tion’ subscale, which has three question items on
satisfaction with study participation (see online supple-
mentary appendix 2). The questionnaire was validated
in English among participants in a randomised clinical
trial of Gulf War veterans’ illnesses. ICQ exhibited good
psychometric properties following standard item-
reduction techniques.35 Similar to DICCQ, the ‘under-
standing’ subscale of ICQ covers the domain on the
meaning of consenting, beneﬁts and risks of trial partici-
pation. However, unlike ICQ, the ‘study expectation’
domain was not covered by DICCQ. ICQ was orally trans-
lated to Mandinka, Fula and Wolof by three independ-
ent native speakers who conﬁrmed consistency with the
original English version. To establish construct validity,
the participants’ scores on ICQ were compared with
their scores on DICCQ.
Sample size estimation
Sample size for validation studies is usually determined
with the aim of minimising SE of the correlation coefﬁ-
cient for reliability test. Also, 4–10 participants per ques-
tion items are recommended to obtain a sufﬁcient
sample size in order to ensure stability of the variance–
covariance matrix in factor analysis.36 37 Based on these
recommendations, we chose seven participants per ques-
tion items. DICCQ has 34 question items (excluding the
ﬁrst 9 questions on sociodemographic data and informa-
tion on previous clinical trial participation) to give
34×7=238 participants. Allowing for a 5% non-response
rate, the sample size was approximated to 250. Half of
these participants (n=125) were invited 1 week after ﬁrst
administration of the questionnaire for a retest. Written
informed consents were obtained from each consenting
participant. Participation was voluntary and conﬁdential.
Scoring system for the questionnaire
The scoring algorithm consistent with the level of
increasing difﬁculty of the question items is summarised
in table 1. In designing the scoring algorithm, we con-
sidered the possibility that certain question items should
attract greater weight than others in determining the
summated scores. For example, closed-ended question
items were scored 0–3, question items with multiple
response options were scored 0–4 and open-ended ques-
tion items with no response option were scored 0–5.
The ﬁrst author, MOA, scored all participants to avoid
inter-rater variations. Participant scores on closed-ended
question items were summed up as the ‘recall’ scores
while participant scores on open-ended question items
were summed as the ‘understanding’ scores. The total
sum of ‘recall’ and ‘understanding’ scores for each par-
ticipant constitutes the ‘comprehension’ scores38 (not
shown in this manuscript).
For ICQ,35 responses were scored as follow: 3 for ‘Yes,
completely’, 2 for ‘Yes, partially’, 1 for ‘I don’t know’
and 0 for ‘No’. The ﬁrst author, MOA, assigned the
scores based on the responses ticked by trained assistants
who administered the questionnaire to the participants.
Data analysis
Data were retrieved from the in-built database of DICCQ
and converted to the Microsoft Excel format. Analysis
was performed with Stata V.12.1 (College Station, USA)
and the Statistical Package for Social Sciences software
V.20.0 (Chicago, Illinois, USA). The signiﬁcance of
Table 1 Scoring of question items
Closed-ended question items in the first section Each correct answer was scored 3; wrong answer was scored
0 and responses with ‘I don’t know’ were scored 1
Open-ended question items which are follow-up questions
to the closed-ended question items in the first section
Each correct answer was scored 5, partially correct answer was
scored 3, incorrect answer was scored 0, while ‘I don’t know’
responses were scored 1
In the second section, participants chose one correct
answer out of four option responses
Each correct answer was scored 3, incorrect answer was
scored 0 and ‘I don’t know’ responses were scored 1
In the third section, participants chose more than one
correct answers from four option responses
Full correct answers were scored 4, partially correct answers
were scored 2, wrong answers were scored 0 and ‘I don’t know’
answers were scored 1
In the fourth section, participants responded using their
own words to open-ended question items
Full correct answer was scored 5, partially correct answers
were scored 3, wrong answers were scored 0 and ‘I don’t know’
responses were scored 1
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group differences was tested by Mann-Whitney U tests
for demographic variables with p<0.05 (two-tailed) con-
sidered as signiﬁcant. Psychometric properties of
DICCQ were evaluated in terms of reliability and validity
using the following steps:
Steps in validation analysis
Construct validity: Construct validity refers to the degree to
which items on the questionnaire relate to the relevant
theoretical construct. It represents the extent to which
the desired independent variable (construct) relates to
the proxy independent variable (indicator).39 40 For
example, in DICCQ, ‘recall’ and ‘understanding’ were
used as indicators of comprehension. This is based on an
earlier study41 which deﬁned ‘recall’ as success in select-
ing the correct answers in the question items and ‘under-
standing’ as correctness of interpretation of statements
presented in the question items. When an indicator con-
sists of multiple question items like in DICCQ, factor ana-
lysis is used to determine construct validity.39 42
To verify construct validity, the design of DICCQ was
analysed in a stepwise procedure. First, we tested whether
the sample size of 250 was sufﬁcient to perform factor ana-
lysis of the 34-item DICCQ according to the Kaiser-
Meyer-Olkin (KMO) coefﬁcient (acceptable value should
be >0.5). In a second step, we conducted a principal com-
ponent analysis (PCA) to derive an initial solution. Third,
we determined the number of factors to be extracted
according to three different criteria: (1) eigenvalue >1, (2)
Cattell’s scree plot and (3) the number of factors identical
with the proposed number of subscales (ie, the ‘recall’
and ‘understanding’ subscales).34 43 In the last step, we
compared the unrotated and the rotated factor solutions.
The rationale of rotating factors is to obtain a simple
factor structure that is more easily interpreted and com-
pared. We chose the varimax rotation as the most com-
monly used orthogonal rotation undertaken to rotate the
factors to maximise the loading on each variable and min-
imise the loading on other factors.34 43 44
Furthermore, owing to a lack of a speciﬁc ‘gold stand-
ard’ tool to measure informed consent comprehension,
we could not examine concurrent (criterion) validity in
which participants’ scores on DICCQ could be com-
pared with the participants’ scores on the ‘gold stand-
ard’ obtained at approximately the same point in time
(concurrently). Nevertheless, construct validity provided
evidence of the degree to which participants’ scores on
the questionnaire were consistent with hypotheses for-
mulated about the relationship of DICCQ with the parti-
cipants’ scores on other instruments measuring similar
or dissimilar constructs, or differences in the instrument
scores between subgroups of study participants.40 Two
forms of construct validity based on hypothesis testing
were examined:
1. Convergent validity: A good example of an instrument
measuring the same construct as DICCQ is ICQ
which contains four question items on
‘understanding’ subscale and three items on ‘satisfac-
tion’ subscale.
The following a priori hypotheses were made: conver-
gent validity—participants’ scores on DICCQ will correl-
ate positively with their scores on ‘understanding’
subscale of ICQ because both constructs relate to
informed consent comprehension in clinical trial con-
texts. However, the correlation is not expected to be
high, because DICCQ covers more domains of informed
consent comprehension than the ICQ subscale.
2. Discriminant validity which examines the extent to
which a questionnaire correlates with other question-
naires of construct that are different from the con-
struct the questionnaire is intended to assess. To
determine this, it was hypothesised that participants’
scores on DICCQ will correlate negatively with the
‘satisfaction’ subscale of ICQ because DICCQ does
not include the ‘satisfaction’ domain about study par-
ticipation. Spearman’s correlation coefﬁcients were
used because the data of the questionnaires (DICCQ
and ICQ) were not normally distributed.
3. To establish further evidence of construct validity, we
examined the discriminative validity in which partici-
pants’ scores on DICCQ were compared between sub-
groups of participants who differed on the construct
being measured. Using the Mann-Whitney U test, the
differences of participants’ scores on DICCQ were com-
pared based on their demographic variables (ie,
gender, place of domicile: urban vs rural and education
status).
Reliability
After completing item reduction in the validity analysis,
the item-reduced DICCQ was investigated for reliability.
Reliability describes the ability of a questionnaire to con-
sistently measure an attribute and how well the question
items conceptually agree together.34 45 Two commonly
used indicators of reliability, internal consistency and
test–retest reliability were employed to examine the reli-
ability of DICCQ. Cronbach’s α was computed to
examine the internal consistency of the questionnaire.
Because the questionnaire contains the ‘recall and
understanding’ subscales, Cronbach’s α was computed
for each subscale as well as for the entire scale. An
acceptable value for Cronbach’s α was ≥0.7.37 39
Test–retest reliability was examined by administering
the same questionnaire to half of the study participants
who were randomly selected on two different occasions,
one week apart. This is based on the assumption that
there would be no substantial change in the comprehen-
sion scores of participants between the two time
points.34 46 A high correlation between the scores at the
two time points indicates that the instrument is stable
over time.34 46 Analysis of participants’ scores between
the test and retest was conducted by estimating the intra-
class correlation coefﬁcients and 95% CI.
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RESULTS
Two hundred and ﬁfty participants consisting of 130 par-
ticipants from the clinical trial in the urban setting and
another 120 clinical trial participants in the rural setting
were interviewed. To address the missing data, partici-
pants (n=3) who did not respond to three or more items
(5%) in DICCQ were excluded from further analysis.44
Those with one or two missing items (n=6) were replaced
with the mean value of the participant scores for the
question item.44 Thus, data from 247 participants were
included in the ﬁnal analysis. The mean age was 37.06
±15 years; there were 129 participants (52.2%) in the
urban group and 118 participants (47.8%) in the rural
group. The overall mean time of administration of the
questionnaire was 22.4±7.4 min while the overall mean
time for retest of the questionnaire was 18.5±5.4 min.
The reduction in duration of administration of the ques-
tionnaire might be because a majority of the participants
became familiar with the question items as a result of the
short interval of one week between the ﬁrst and second
administration.
The sociodemographic characteristics of the study par-
ticipants are summarised in table 2.
Table 2 shows that a majority of the participants
(about 27%) were in the age group 18–25 years; about
63% were women and about 40% had no formal educa-
tion. The index trial was the ﬁrst clinical exposure in
81% of the participants, while the rest had participated
in at least one trial apart from the current trial.
Factor analysis
The KMO coefﬁcient for DICCQ was 0.62 (acceptable
value was >0.5), conﬁrming a sufﬁcient degree of
common variance and the factorability of the intercor-
relation matrix of the 34 items. The ﬁrst PCA yielded a
total variance of 69.02%, which implied that at least
50% of the variance could be explained by common
factors, and this is considered acceptable. This initial
solution after PCA revealed 13 components with eigen-
values >1. However, the scree plot began to level off
after two components, consistent with the number of
subscales (ﬁgure 1). As the scree plot is considered
more accurate in determining the numbers of factors to
retain especially when the sample size is ≥250, or the
questionnaire has more than 30 items,42 a two factor
solution with varimax rotation was considered conceptu-
ally relevant and statistically appropriate for DICCQ. To
give the correct explanation, the values of factor load-
ings were checked using Steven’s guideline of acceptable
value of 0.29–0.38 for a sample size of 200–300 partici-
pants.42 As the sample size used in this study was 250,
eight items: two items on study duration, four items on
the funder/sponsor of the study and two items on the
number of study participants with factor loadings of
<0.3, were deleted. Five items: voluntary participation,
rights of withdrawal, placebo, blinding and study
purpose, were retained despite low factor loadings
because they were theoretically important components
of informed consent. The ﬁnal PCA of the two-factor
solution with 26 items (corresponding to ‘recall and
understanding’ themes) accounted for 60.25% of the
total variance. The factor loadings of the ﬁnal PCA and
their factorial weights are shown in table 3.
Figure 1 Cattell’s scree plot for the item-level factor
analysis.
Table 2 Sociodemographic characteristics of study
participants
Characteristics Frequency (%; N=247)
Age group (years)
18–25 67 (26.8)
26–33 65 (26.0)
34–41 40 (16.0)
42–49 23 (9.2)
>49 55 (22.0)
Gender
Female 156 (63.2)
Male 91 (36.8)
Domicile
Urban 129 (52.2)
Rural 118 (47.8)
Occupation
Farming 80 (32.3)
Trading 39 (15.8)
Artisans 7 (2.8)
Civil servant 18 (7.3)
Housewife 94 (38.2)
Schooling 4 (1.6)
Unemployed 5 (2.0)
Education group
Had western education 62 (25.1)
Had no western education 185 (74.9)
Religious affiliation
Islam 239 (96.8)
Christianity 8 (3.2)
Previous clinical trial participation
Only one 200 (81.0)
More than one 47 (19.0)
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Table 3 shows that the factorial weights of each item of
the two components are greater than 0.3 and that
Cronbach’s α coefﬁcient of each component is greater
than 0.7, suggesting high internal consistency.
Internal consistency reliability
Cronbach’s α computed for the item-reduced DICCQ
was 0.79 and 0.73, respectively, for ‘recall and under-
standing’ domains. This indicates a high correlation
between the items and that the questionnaire is reliable.
Test–retest reliability
One hundred and twenty-six (51%) of 247 participants
completed the second questionnaire at a mean of
7.5 days after the ﬁrst administration. The mean age of
respondents who had a retest was 36.9±15.1 years; 77
(60.6%) were women and 50 (39.4%) were men; 60
(47.2%) were from a rural setting while 67 (52.8%) lived
in the city. The average time of administration was 18.5
±5.4 min (range 9–39 min). An intraclass correlation
coefﬁcient of 0.94 (95% CI 0.923 to 0.954) was obtained,
showing that the questionnaire was consistently reliable
over the two periods of administration.
Validity
Convergent validity
To test the expected relationships between DICCQ and
ICQ, we correlated total DICCQ scores with ICQ
scores in the sample population (n=247). As expected,
DICCQ was signiﬁcantly positively correlated with the
‘understanding’ subscale of ICQ (r=0.306, p<0.001).
These ﬁndings provide some evidence of convergent
validity.
Discriminant validity
Also as predicted, DICCQ was signiﬁcantly negatively cor-
related with the ‘satisfaction’ subscale of ICQ (r=−0.105,
p=0.049), providing evidence of discriminant validity.
Discriminative validity
Expectedly, there was a signiﬁcant statistical difference
in the comprehension scores on DICCQ among female
and male participants (z=8.8, p<0.001), rural and urban
participants (z=−11.1, p<0.001) and educated and
non-educated participants (z=4.27, p<0.001). This pro-
vides further evidence of construct validity (table 4).
Table 4 shows that there were signiﬁcant differences in
the comprehension scores of participants based on
gender, place of domicile and education status.
Table 3 Principal component analysis (PCA) with varimax rotation: final two-component solution and Cronbach’s α of each
component
PCA factor loadings
Recall items (n=17): closed-ended and multiple choice response formats (Cronbach’s α=0.79)
Told I can freely take part 0.719
Told I can withdraw anytime 0.314
Will know the study drug/vaccine 0.552
Unauthorised person will not know about my participation 0.372
Told the contact person 0.540
My participation can be stopped without my consent 0.420
Will I be paid for taking part 0.395
How were participants divided into groups 0.403
At what point can I leave the study 0.371
Meaning of signing/thumb-printing consent form 0.390
How I decided to take part 0.429
What will I receive as compensation 0.520
What will happen if I decide to withdraw 0.464
Reason for doing the parent study 0.393
Which are the study procedures 0.489
Which are the study activities 0.617
Which are the main benefits of taking part 0.390
Understanding items: open-ended response format (n=9; Cronbach’s α=0.73)
Describe the function of the study drug/vaccine 0.647
Mention the name of the contact person 0.451
Tell what researchers want to find in this study 0.312
Number of study visits 0.492
Tell what were done during the study visits 0.498
Describe how participants were divided 0.689
Tell the difference between taking part in a study and going to hospital 0.464
What are the possible unwanted effects of a study drug/vaccine 0.388
Why were participants given different drugs/vaccines 0.437
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DISCUSSION
This study reports the psychometric properties of a digi-
tised audio informed consent comprehension question-
naire when tested in a sample of clinical trial
participants in urban and rural settings in the Gambia.
This is the ﬁrst validation process of the questionnaire
and the results suggest that it has good psychometric
properties. The digitised audio questionnaire in local
languages could be useful as a measure of comprehen-
sion of informed consent. DICCQ demonstrated good
internal consistency and convergent, discriminant and
discriminative validity. This study adds to knowledge by
demonstrating that the digitised questionnaire can be
developed and psychometrically evaluated in three dif-
ferent oral languages.
Expectedly, DICCQ scores were signiﬁcantly positively
correlated with the ‘understanding’ subscale of ICQ,
and signiﬁcantly negatively correlated with the ‘satisfac-
tion’ subscale of the questionnaire. These signiﬁcant
correlations are evidence of convergent and discrimin-
ant validity of DICCQ, because DICCQ scores correlated
with scores on ICQ in the theoretically expected direc-
tions. Furthermore, there were signiﬁcant statistical dif-
ferences in the participants’ scores on DICCQ based on
their gender, domicile and education status (p<0.0001),
providing evidence of the discriminative validity of the
questionnaire. Taken together, these ﬁndings establish a
construct validity of DICCQ.
This innovative approach of developing and delivering
questions has enabled a rapid measurement of informed
consent comprehension in rural, remote and urban
research settings. It overcomes the obstacles of multiple
written translations, which are quite challenging in some
African countries due to the lack of standardised written
languages and low literacy. The use of orally recorded
interpretations of the questionnaire and delivery
through a digitalised format ensured that the questions
were consistently presented to all participants. Given
that the communication skills of an interviewer could
inﬂuence comprehension of the information, it was
important that we used experienced native speakers
to interpret the English version of the questionnaire
to Gambian local languages that were understandable to
the participants in rural and urban settings.
Nevertheless, we fully recognise that it could be coun-
terproductive to depend solely on the technology of a
tool to meet the comprehension assessment of partici-
pants during informed consent process; hence, we
involved trained interviewers to administer the audio
computerised questionnaire to the participants. In our
study, we ensured that the research team had sufﬁcient
time to discuss participants’ concerns about the research,
in addition to the use of the comprehension tool. Thus,
we believe that the overall acceptance and success of the
tool will ultimately depend on a well-balanced combin-
ation of the technology and human elements.38
The questionnaire software also has an in-built data-
base which minimises errors in data entry and reduces
data entry time. This improves the accuracy and quality
of the data and ultimately the psychometric properties
of the questionnaire.
Another important strength of this study is the reason-
able sample sizes used in the rural and urban popula-
tions. Almost 99% of the participants for the ﬁrst and
retest questionnaires completed the study. The represen-
tative sample and high response rates could be due to
the fact that the participants were recruited from
ongoing clinical trials with regimented study visits. Also,
the strategy used in administering the questionnaire in
the local languages of choice of the participants encour-
aged greater participation and high retention rates.
A major limitation could be that this experience is
very speciﬁc to the Gambia, a relatively small country
with three major local languages. It may be challenging
to translate this experience to other contexts. Also, the
scoring of all participant assessments by a single
researcher eliminated inter-rater variability, which could
create a possibility of error that might lead to underesti-
mation or overestimation of participants’ comprehen-
sion scores. Nevertheless, this effort represents an
important development towards improving informed
consent comprehension. Until now, a lot of literature
has explained the challenges of informed consent com-
prehension in resource-poor contexts, but few concrete
recommendations have improved it. If DICCQ can help
to identify elements of informed consent which are less
understood in a speciﬁc context, then further work
could be carried out with a multidisciplinary team and
the community for developing better approaches, word-
ings and examples for describing those aspects which
are more difﬁcult to understand in that very context.
This will, in addition to improving participants’ compre-
hension, protect their freedom to decide, and also
potentially improve the quality of data and outcome of
the research.
Another limitation of this study is that known group
validity and sensitivity to change could not be deter-
mined. This is because known group validity requires a
Table 4 Discriminative validity showing differences of
comprehension scores by participants’ demographic
variables
Rank
sum Expected Significance
Gender
Male (n=91) 5765.5 11 284 z=8.80,
p<0.001Female (n=156) 24 862.5 19 344
Domicile
Urban (n=129) 7640.5 14 632 z=−11.1,
p<0.001Rural (n=118) 22 987.5 15 996
Education status
Educated (n=62) 9765 7688 z=4.27,
p<0.0001No western
education (n=185)
20 863 22 940
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strong a priori hypothesis that groups differ on the con-
struct. There is insufﬁcient previous research on
informed consent comprehension to develop strong a
priori expectations about differences in comprehension
levels between different subgroups of participants.
There is an expectation of higher comprehension levels
when the tool is used following an intervention, which
will make a preintervention and postintervention com-
parison test a test of sensitivity to change and of known
group validity. This will be explored in a future study
where the ability of the questionnaire to detect changes
in the participants’ level of comprehension will be calcu-
lated by determining the effect size and the standardised
response means.
CONCLUSIONS
DICCQ was developed using a combination of inter-
national and local guidelines. The present study suggests
that the questionnaire has two factors, consistent with
the deﬁnition proposed by Minnies et al41 suggesting
comprehension as comprising recall and understanding
components.
We conclude that DICCQ not only has good psycho-
metric properties, but also has potential as a useful
measure of comprehension of informed consent among
clinical trial participants in low-literacy communities. As
with all psychometric instruments, the evidence for the
psychometric properties and usefulness of DICCQ for
evaluating informed consent comprehension will be
strengthened by further research. In particular, it will be
important to (1) test the psychometric properties of the
questionnaire in other African populations, (2) conduct
long-term follow-up studies and (3) explore the proper-
ties of DICCQ in different phases of clinical trials, in
particular preventive and therapeutic trials. This will
enable predictive testing including further tests of
known group validity; overall, it will also provide us with
more reliable information to improve the process of
informed consent in African contexts, in a relationship
of mutual partnership between study participants and
researchers.
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